Literature DB >> 10947517

When is an HIV infection prevented and when is it merely delayed?

S D Pinkerton1, H W Chesson, D R Holtgrave, W Kassler, P M Layde.   

Abstract

HIV prevention programs are typically evaluated using behavioral outcomes. Mathematical models of HIV transmission can be used to translate these behavioral outcomes into estimates of the number of HIV infections averted. Usually, intervention effectiveness is evaluated over a brief assessment period and an infection is considered to be prevented if it does not occur during this period. This approach may overestimate intervention effectiveness if participants continue to engage in risk behaviors. Conversely, this strategy underestimates the true impact of interventions by assuming that behavioral changes persist only until the end of the intervention assessment period. In this article, the authors (a) suggest a simple framework for distinguishing between HIV infections that are truly prevented and those that are merely delayed, (b) illustrate how these outcomes can be estimated, (c) discuss strategies for extrapolating intervention effects beyond the assessment period, and (d) highlight the implications of these findings for HIV prevention decision making.

Entities:  

Mesh:

Year:  2000        PMID: 10947517     DOI: 10.1177/0193841X0002400301

Source DB:  PubMed          Journal:  Eval Rev        ISSN: 0193-841X


  3 in total

1.  Condom distribution in jail to prevent HIV infection.

Authors:  Arleen A Leibowitz; Nina Harawa; Mary Sylla; Christopher C Hallstrom; Peter R Kerndt
Journal:  AIDS Behav       Date:  2013-10

2.  The economic impact of project MARS (motivating adolescents to reduce sexual risk).

Authors:  Bern C Dealy; Brady P Horn; Tiffany J Callahan; Angela D Bryan
Journal:  Health Psychol       Date:  2013-09       Impact factor: 5.556

3.  Formulas for estimating the costs averted by sexually transmitted infection (STI) prevention programs in the United States.

Authors:  Harrell W Chesson; Dayne Collins; Kathryn Koski
Journal:  Cost Eff Resour Alloc       Date:  2008-05-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.